Atria Investments Inc Has $15.08 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Atria Investments Inc Has $15.08 Million Stock Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co Company News
Merck's 2026 outlook clouds upbeat fourth-quarter results - Reuters
Merck's 2026 outlook clouds upbeat fourth-quarter results Reuters
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace
Insider Sell: Chirfi Guindo Sells 10,000 Shares of Merck & Co In - GuruFocus
Insider Sell: Chirfi Guindo Sells 10,000 Shares of Merck & Co In GuruFocus
Merck & Co., Inc. (MRK) Joins BofA’s “US 1 List” - Yahoo Finance
Merck & Co., Inc. (MRK) Joins BofA’s “US 1 List” Yahoo Finance
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline - Business Wire
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline Business Wire
Rhumbline Advisers Sells 8,850 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rhumbline Advisers Sells 8,850 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck no longer in talks to buy Revolution Medicines, WSJ reports - Reuters
Merck no longer in talks to buy Revolution Medicines, WSJ reports Reuters
Merck & Co., Inc. $MRK Shares Sold by Applied Finance Capital Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Applied Finance Capital Management LLC MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) EVP Sells $14,485,422.95 in Stock MarketBeat
Merck & Co., Inc. $MRK Position Increased by Providence Capital Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Position Increased by Providence Capital Advisors LLC MarketBeat
Advisors Asset Management Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Advisors Asset Management Inc. Grows Holdings in Merck & Co., Inc. $MRK MarketBeat
Stratos Wealth Partners LTD. Acquires 26,639 Shares of Merck & Co., Inc. $MRK - MarketBeat
Stratos Wealth Partners LTD. Acquires 26,639 Shares of Merck & Co., Inc. $MRK MarketBeat
Rockland Trust Co. Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Rockland Trust Co. Boosts Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Wealthfront Advisers LLC Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Wealthfront Advisers LLC Raises Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Wesbanco Bank Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Wesbanco Bank Inc. MarketBeat
ING Groep NV Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
ING Groep NV Raises Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Stock Position Reduced by Candriam S.C.A. - MarketBeat
Merck & Co., Inc. $MRK Stock Position Reduced by Candriam S.C.A. MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ProShare Advisors LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by ProShare Advisors LLC MarketBeat
Alps Advisors Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Alps Advisors Inc. Lowers Position in Merck & Co., Inc. $MRK MarketBeat
Merck Vaccine Sales Drop as US Declines Strike Another Pharma - BioSpace
Merck Vaccine Sales Drop as US Declines Strike Another Pharma BioSpace
How To Win Deals In A Competitive Market, With Merck & Co. BD Exec Elizabeth Naldi-Jacob - Citeline News & Insights
How To Win Deals In A Competitive Market, With Merck & Co. BD Exec Elizabeth Naldi-Jacob Citeline News & Insights
Merck & Co to cut 6000 jobs, Moderna to cut around 500 - Chemistry World
Merck & Co to cut 6000 jobs, Moderna to cut around 500 Chemistry World
Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares - Reuters
Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares Reuters
Our Q2 2025 financial results - Merck
Our Q2 2025 financial results Merck
Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s - Yahoo Finance
Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s Yahoo Finance
Merck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley - Virginia Mercury
Merck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley Virginia Mercury
Merck scraps £1bn expansion in the UK over lack of state investment - BBC
Merck scraps £1bn expansion in the UK over lack of state investment BBC
Merck plans spending shift to boost business beyond Keytruda - BioPharma Dive
Merck plans spending shift to boost business beyond Keytruda BioPharma Dive
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook - CNBC
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook CNBC
Merck executes its own Brexit, moving all R&D operations out of UK - Fierce Biotech
Merck executes its own Brexit, moving all R&D operations out of UK Fierce Biotech
As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start - Fierce Pharma
As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start Fierce Pharma
Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks - Yahoo Finance
Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks Yahoo Finance
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees - BioSpace
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees BioSpace
Merck to build $3B facility in Elkton - Virginia Business
Merck to build $3B facility in Elkton Virginia Business
Do You Believe in Merck & Co.’s (MRK) Upside Potential? - Yahoo Finance
Do You Believe in Merck & Co.’s (MRK) Upside Potential? Yahoo Finance
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity - BioSpace
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity BioSpace
Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers - Reuters
Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers Reuters
Where is Merck & Co. (MRK) Headed According to Analysts? - Yahoo Finance
Where is Merck & Co. (MRK) Headed According to Analysts? Yahoo Finance
Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s - Reuters
Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s Reuters